Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Active not recruiting 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 1Human Papillomavirus-Related Cervical Carcinoma 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 5Prednisone 3Dexamethasone 3Cisplatin 3Atorvastatin 3olaparib 2lorlatinib 2human papillomavirus vaccine, L1 type 16, 18 2enzalutamide 2adacel 2Tobacco Use Cessation Devices 2Tetanus Toxoid 2Papillomavirus Vaccines 2Letrozole 2Diphtheria-Tetanus-acellular Pertussis Vaccines 2Diphtheria Toxoid 2Denosumab 2Carboplatin 2Anesthesia, Epidural 2Abiraterone Acetate 2xiapex 1venetoclax 1tirbanibulin 1tenofovir alafenamide 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1ribociclib 1radium Ra 223 dichloride 1pembrolizumab 1pasireotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Active not recruiting × adacel × Clear all
NCT05237947 2026-05-28

PRISMA

National Cancer Institute (NCI)

Phase 4 Active not recruiting
5,000 enrolled
Gynecologic

Human Papillomavirus-Related Cervical Carcinoma

NCT03180034 2025-09-04

ESCUDDO

National Cancer Institute (NCI)

Phase 4 Active not recruiting
27,945 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡